2022


  1. Teichgräber U, Lehmann T, Aschenbach R, Thieme M, Zeller T, Beschorner U, Scheinert D (2022). Femoropopliteal Drug-coated Balloon Angioplasty: Long-term Results of the Randomized EffPac Trial. Radiology, 304(1), 225-227.
     
  2. Steiner S, Honton B, Langhoff R, Chiesa R, Kahlberg A, Thieme M, Zeller T, Garot P, Commeau P, Cremonesi A, Marone EM, Sauguet A, Scheinert D (2022). 2-Year Results With a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study. JACC Cardiovasc Interv, 15(6), 618-626.
     
  3. Wittig T, Schmidt A, Kabelitz M, Hukauf M, Pflug T, Scheinert D, Steiner S (2022). Safety and Efficacy of All Comers Treated with a Paclitaxel Coated Balloon for Below Knee Intervention. Eur J Vasc Endovasc Surg, 64(5), 516-525.
     
  4. Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Popescu C, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Beschorner U, Wittig T, Scheinert D (2022). Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE Trial. JACC Cardiovasc Interv, 15(20), 2093-2102.
     
  5. Bakker O, Bausback Y, Wittig T, Branzan D, Steiner S, Fischer A, Konert M, Düsing S, Banning-Eichenseer U, Scheinert D, Schmidt A (2022). First Experience With The GoBack-Catheter For Successful Crossing of Complex Chronic Total Occlusions in Lower Limb Arteries. J Endovasc Ther, 29(5), 798-807.
     
  6. Teichgräber U, Lehmann T, Ingwersen M, Aschenbach R, Zeller T, Brechtel K, Blessing E, Lichtenberg M, von Flotow P, Heilmeier B, Sixt S, Brucks S, Erbel C, Beschorner U, Werk M, Riambau V, Wienke A, Klumb C, Thieme M, Scheinert D (2022). Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial. Cardiovasc Intervent Radiol, 45(12), 1774-1783.
     
  7. Steiner S, Schmidt A (2022). [Endovascular interventions for peripheral arterial disease]. Inn Med (Heidelb), 63(6), 584-590.
     
  8. Hatzl J, Batenburg MVB, Yeung KK, Fioole B, Verhoeven E, Lauwers G, Kölbel T, Wever JJ, Scheinert D, Van den Eynde W, Rouhani G, Mees BME, Vermassen F, Schelzig H, Cuypers PWM, Böckler D (2022). Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha? Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Ann Vasc Surg, 78(), 170-179.
     
  9. Teichgräber U, Platzer S, Lehmann T, Ingwersen M, Aschenbach R, Beschorner U, Scheinert D, Zeller T (2022). Sirolimus-Coated Balloon Angioplasty of Infra-popliteal Lesions for the Treatment of Chronic Limb-Threatening Ischemia: Study Protocol for the Randomized Controlled LIMES Study. Cardiovasc Intervent Radiol, 45(11), 1716-1724.
     
  10. Zeller T, Brodmann M, Ansel GM, Scheinert D, Choi D, Tepe G, Menk J, Micari A (2022). Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT Global Study. EuroIntervention, (), 01098.
     
  11. Torsello G, Bertoglio L, Kellersmann R, Wever JJ, van Overhagen H, Stavroulakis K (2022). One-year results of the INSIGHT study on endovascular treatment of abdominal aortic aneurysms. J Vasc Surg, 75(6), 1904-1911.
     
  12. Shishehbor MH, Scheinert D, Jain A, Brodmann M, Tepe G, Ando K, Krishnan P, Iida O, Laird JR, Schneider PA, Rocha-Singh KJ, Zeller T (2022). Comparison of Drug-coated Balloons versus Bare Metal Stents in Patients with Femoropopliteal Arterial Disease. J Am Coll Cardiol, (), 07161-3.
     
  13. Langhoff R, Petrov I, Kedev S, Milosevic Z, Schmidt A, Scheinert D, Schofer J, Sievert H, Sedgewick G, Saylors E, Sachar R, Cremonesi A, Micari A (2022). PERFORMANCE 1 study: Novel carotid stent system with integrated post-dilation balloon and embolic protection device. Catheter Cardiovasc Interv, 100(6), 1090-1099.
     
  14. Korosoglou G, Schmidt A, Stavroulakis K, Pollert D, Giusca S, Lichtenberg M, Scheinert D, Torsello G, Andrassy M, Blessing E (2022). Retrograde Access for the Recanalization of Lower-Limb Occlusive Lesions: A German Experience Report in 1,516 Consecutive Patients. JACC Cardiovasc Interv, 15(3), 348-351.
     
  15. Krishnan P, Farhan S, Schneider P, Kamran H, Iida O, Brodmann M, Micari A, Sachar R, Urasawa K, Scheinert D, Ando K, Tarricone A, Doros G, Tepe G, Yokoi H, Laird J, Zeller T (2022). Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention. J Am Coll Cardiol, 80(13), 1241-1250.
     
  16. Berland T, Clement J, Inston N, Kreienberg P, Ouriel K (2022). Percutaneous arteriovenous fistula creation with the 4F WavelinQ EndoAVF System. J Vasc Surg, 75(3), 1038-1046.
     
  17. Halena G, Krievins DK, Scheinert D, Savlovskis J, Szopi?ski P, Krämer A, Ouriel K, Schmidt A, Zdunek M, Lyden SP (2022). Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System. J Endovasc Ther, 29(1), 84-95.
     
  18. Mazurek A, Malinowski K, Rosenfield K, Capoccia L, Speziale F, de Donato G, Setacci C, Wissgott C, Sirignano P, Tekieli L, Karpenko A, Kuczmik W, Stabile E, Metzger DC, Amor M, Siddiqui AH, Micari A, Pieni??ek P, Cremonesi A, Schofer J, Schmidt A, Musialek P (2022). Clinical Outcomes of Second- versus First-Generation Carotid Stents: A Systematic Review and Meta-Analysis. J Clin Med, 11(16), 4819.
     
  19. Giusca S, Schmidt A, Korosoglou G (2022). A case report of distal radial puncture in a patient with acute upper limb ischaemia: the last hope of the cardiologist? Eur Heart J Case Rep, 6(7), 215.
     
  20. Zeller T, Giannopoulos S, Brodmann M, Werner M, Andrassy M, Schmidt A, Blessing E, Tepe G, Armstrong EJ (2022). Orbital Atherectomy Prior to Drug-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions: A Randomized, Multicenter Pilot Study. J Endovasc Ther, 29(6), 874-884.
     
  21. Geisler A, Schmidt A, Branzan D (2022). [Digital Patient Data, Artificial Intelligence and Machine Learning in the New Era of Endovascular Aortic Therapies]. Zentralbl Chir, 147(5), 432-438.
     


  22. 2021


  23. Branzan D, Geisler A, Steiner S, Doss M, Matschuck M, Scheinert D, Schmidt A (2021). Type II endoleak and aortic aneurysm sac shrinkage after preemptive embolization of aneurysm sac side branches. J Vasc Surg, 73(6), 1973-1979.e1.
     
  24. Laird JR, Mathews SJ, Brodmann M, Soukas PA, Schmidt A (2021). Performance of the Wingman catheter in peripheral artery chronic total occlusions: Short-term results from the international Wing-It trial. Catheter Cardiovasc Interv, 97(2), 310-316.
     
  25. Steiner S, Schmidt A (2021). Repeat BTK revascularization: when, how and what are the results? J Cardiovasc Surg (Torino), 62(2), 118-123.
     
  26. Branzan D, Geisler A, Grunert R, Steiner S, Bausback Y, Gockel I, Scheinert D, Schmidt A (2021). The Influence of 3D Printed Aortic Models on the Evolution of Physician Modified Stent Grafts for the Urgent Treatment of Thoraco-abdominal and Pararenal Aortic Pathologies. Eur J Vasc Endovasc Surg, 61(3), 407-412.
     
  27. Branzan D, Geisler A, Steiner S, Lautenschlaeger T, Doss M, Matschuck M, Scheinert D, Schmidt A (2021). Stroke rate after thoracic endovascular aortic repair using de-airing of stentgrafts with high-volume of saline solution. Vasa, 50(3), 186-192.
     
  28. Wittig T, Zeller T, Bosiers M, Peeters P, Brucks S, Bausback Y, Schmidt A, Scheinert D, Steiner S (2021). Assessment of 5-Year Mortality Outcomes for Femoropoliteal Interventions Using Drug-Eluting Devices in the REAL-PTX Study. JACC Cardiovasc Interv. , 14, 1165-1168.
     
  29. Teichgraber U, Ingwersen M, Platzer S, Lehmann T, Zeller T, Aschenbach R, Scheinert D (2021). Head-to-head comparison of sirolimus-versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial Trials, 22, 665.
     
  30. Bakker O, Bausback Y, Wittig T, Branzan D, Steiner S, Fischer A, Konert M, Düsing S, Banning-Eichenseer U, Scheinert D, Schmidt A (2021). First Experience With The GoBack-Catheter For Successful Crossing of Complex Chronic Total Occlusions in Lower Limb Arteries. J Endovasc Ther, (), 15266028211065962.
     
  31. Geraghty PJ, Adams G, Schmidt A (2021). Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries. J Vasc Surg, 73(3), 918-929.
     
  32. Korosoglou G, Giusca S, Antaredja M, Schmidt A, Blessing E (2021). Distal retrieval of dislodged and migrated guidewires after retrograde puncture of the deep femoral and dorsal pedal artery. A case series. Clin Case Rep, 9(4), 2077-2082.
     
  33. Floros N, Kölbel T, Tsilimparis N, Oberhuber A, Kindl D, Kalder J, Kotelis D, Schmidt A, Branzan D, Adolf D, Schelzig H, Wagenhäuser MU (2021). First-in-Human Clinical Application of the Medyria TrackCath System in Endovascular Repair of Complex Aortic Aneurysms (ACCESS Trial): A Prospective Multicenter Single-Arm Clinical Trial. J Endovasc Ther, 28(6), 914-926.
     
  34. Langhoff R, Arjumand J, Waliszewski M, Reimer P, Härtel D, Hohl C, Raut W, Romani S, Alós J, Martínez E, Schmidt A, Yahya SA, Riazi H, Korosoglou G (2021). The Real-World CONSEQUENT ALL COMERS Study: Predictors for Target Lesion Revascularization and Mortality in an Unselected Patient Population. Angiology, 72(8), 724-732.
     
  35. Böhme T, Noory E, Beschorner U, Lerke F, Schmidt A, Scheinert D, Ito W, Zeller T, Rastan A (2021). Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions (PHOTOPAC). Vasa, 50(5), 387-393.
     
  36. Giusca S, Schmidt A, Korosoglou G (2021). 'Pave-and-crack' technique for the recanalization of severely calcified occlusive aorto-ilio-femoral disease in type-III Leriche syndrome: a case report. Eur Heart J Case Rep, 5(2), 059.
     
  37. Schneider PA, Krievins DK, Halena G, Schmidt A, Lyden S, Lee V, Hu M, Adelman M (2021). Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass. J Vasc Surg Venous Lymphat Disord, 9(5), 1266-1272.
     
  38. Geisler A, Steiner S, Schmidt A, Scheinert D, Branzan D (2021). [Surgeon-modified Stent Grafts for Complex Aortic Reconstructions - What is Feasible?] Zentralbl Chir, 146(5), 486-492.
     
  39. Halena G, Krievins DK, Scheinert D, Savlovskis J, Szopi?ski P, Krämer A, Ouriel K, Schmidt A, Zdunek M, Lyden SP (2021). Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System. J Endovasc Ther, (), 15266028211034862.
     
  40. Halliday A, Bulbulia R, Bonati LH, Chester J, Cradduck-Bamford A, Peto R, Pan H (2021). Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet, 398(10305), 1065-1073.
     
  41. D'Oria M, Pitoulias GA, Torsello GF, Pitoulias AG, Fazzini S, Masciello F, Verzini F, Donas KP, pELVIS Registry Investigators (2021). Bilateral Use of Iliac Branch Devices for Aortoiliac Aneurysms Is Safe and Feasible, and Procedural Volume Does Not Seem to Affect Technical or Clinical Effectiveness: Early and Midterm Results From the pELVIS International Multicentric Registry. J Endovasc Ther., 17, 15.
     
  42. Fargion AT, Masciello F, Pratesi G, Torsello G, Donas KP, Pratesi C (2021). Results of Iliac Branch Devices in Octogenarians Within the pELVIS Registry. J Endovasc Ther, 28(1), 157-164.
     
  43. Tepe G, Brodmann M, Werner M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, Nolte-Ernsting C, Bertolet B, Scheinert D, Gray WA (2021). Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial. JACC Cardiovasc Interv, 14(12), 1352-1361.
     


  44. 2020


  45. Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Ulrich M, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Scheinert D (2020). COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J, 41(27), 2541-2552.
     
  46. Teichgräber U, Lehmann T, Aschenbach R, Thieme M, Zeller T, Beschorner U, Scheinert D (2020). Two-year Review on Mortality and Morbidity after Femoropopliteal Drug-coated Balloon Angioplasty in the Randomized EffPac Trial. Radiology, 296(3), 638-640.
     
  47. Krievins DK, Halena G, Scheinert D, Savlovskis J, Szopi?ski P, Krämer A, Ouriel K, Nair K, Holden A, Schmidt A (2020). One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass. J Vasc Surg, (), 1-10.
     
  48. Daniela Branzan 1 , Antonia Geisler 2 , Sabine Steiner 3 , Markus Doss 2 , Manuela Matschuck 3 , Dierk Scheinert 3 , Andrej Schmidt 3 (2020). Type II Endoleak and Aortic Aneurysm Sac Shrinkage following Pre-emptive Embolization of Aneurysm Sac Side Branches J Vasc Surg, S0741, 32504.
     
  49. Schmidt A, Schreve MA, Huizing E, Del Giudice C, Branzan D, Ünlü Ç, Varcoe RL, Ferraresi R, Kum S (2020). Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study. J Endovasc Ther, 27(4), 658-665.
     
  50. Schmidt A, Schreve MA, Huizing E, Del Giudice C, Branzan D, Ünlü Ç, Varcoe RL, Ferraresi R, Kum S (2020). Reply to "More Data Are Needed to Elucidate the Achilles' Heel of Percutaneous Deep Venous Arterialization". J Endovasc Ther, 27(5), 874-876.
     
  51. Krievins DK, Halena G, Scheinert D, Savlovskis J, Szopi?ski P, Krämer A, Ouriel K, Nair K, Holden A, Schmidt A (2020). One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass. J Vasc Surg, 72(5), 1648-1658.e2.
     
  52. Haensig M, Schmidt A, Staab H, Steiner S, Scheinert D, Branzan D (2020). Endovascular Repair of the Thoracic or Thoracoabdominal Aorta Following the Frozen Elephant Trunk Procedure. Ann Thorac Surg, 109(3), 695-701.
     
  53. Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, Banyai M, Shishehbor MH, Wang H, Brodmann M (2020). The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. JACC Cardiovasc Interv, 13(4), 431-443.
     
  54. Bosiers M, Setacci C, De Donato G, Torsello G, Silveira PG, Deloose K, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Callaert J, Eckstein HH, Te?arek J, Giaquinta A, Wauters J (2020). ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions. J Endovasc Ther, 27(2), 287-295.
     
  55. Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, Sixt S, Brucks S, Beschorner U, Klumb CT, Thieme M (2020). Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial. EuroIntervention, 15(18), 1633-1640.
     
  56. Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, von Flotow P, Heilmeier B, Sixt S, Brucks S, Erbel C, Beschorner U, Werk M, Riambau V, Wienke A, Klumb CT, Thieme M (2020). Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial. Radiology, 295(2), 478-487.
     
  57. Welling RHA, de Borst GJ, van den Heuvel DAF, Branzan D, Schmidt A, Scheinert D, Bakker OJ (2020). Vessel Calcification Patterns Should Determine Optimal Balloon Size Strategy in Below the Knee Angioplasty Procedures. Eur J Vasc Endovasc Surg, (), 1-2.
     
  58. Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T (2020). Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort. J Endovasc Ther, (), 1526602820931477.
     
  59. Bosiers M, Deloose K, Torsello G, Scheinert D, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K, Hendriks J, Callaert J, Bosiers M, Wauters J (2020). One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions. J Cardiovasc Surg (Torino), 61(4), 471-477.
     
  60. Böhme T, Noory E, Brechtel K, Scheinert D, Bosiers M, Beschorner U, Zeller T (2020). Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial. J Endovasc Ther, (), 1526602820965965.
     
  61. Marc Bosiers 1 , Koen Deloose 2 , Joren Callaert 2 , Jürgen Verbist 3 , Jeroen Hendriks 4 , Patrick Lauwers 4 , Herman Schroë 5 , Wouter Lansink 5 , Dierk Scheinert 6 , Andrej Schmidt 6 , Thomas Zeller 7 , Ulrich Beschorner 7 , Elias Noory 7 , Giovanni Torsello 8 , Martin Austermann 8 , Jeroen Wauters 9 (2020). Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial J Cardiovasc Surg (Torino), 61(5), 6176-25.
     
  62. Geraghty PJ, Adams G, Schmidt A (2020). 6-Month Pivotal Results of Tack Optimized Balloon Angioplasty using the Tack Endovascular System® in Below-the-Knee Arteries. J Vasc Surg, (20), 32060-7.
     
  63. Graham GV, Conlon JM, Abdel-Wahab YH, Flatt PR (2020). Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities. Eur J Pharmacol, 878(), 173101.
     
  64. Rümenapf G, Morbach S, Schmidt A, Sigl M (2020). Intermittent Claudication and Asymptomatic Peripheral Arterial Disease. Dtsch Arztebl Int, 117(11), 188-193.
     


  65. 2019


  66. Steiner S, Sauguet A, Langhoff R, Kahlberg A, Thieme M, Zeller T, Garot P, Commeau P, Cremonesi A, Marone EM, Scheinert D (2019). First-in-Human Experience With Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions. J Am Coll Cardiol, 74(17), 2216-2218.
     
  67. Schmidt A, Bausback Y, Piorkowski M, Wittig T, Banning-Eichenseer U, Thiele H, Aldmour S, Branzan D, Scheinert D, Steiner S (2019). Retrograde Tibioperoneal Access for Complex Infrainguinal Occlusions: Short- and Long-Term Outcomes of 554 Endovascular Interventions. JACC Cardiovasc Interv, 12(17), 1714-1726.
     
  68. Branzan D, Steiner S, Haensig M, Scheinert D, Schmidt A (2019). Percutaneous Axillary Artery Access for Endovascular Treatment of Complex Thoraco-abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg, 58(3), 344-349.
     
  69. Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, Brucks S, Lottes AE, Scheinert D, Steiner S (2019). Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease. J Am Coll Cardiol, 73(6), 667-679.
     
  70. Steiner S, Schmidt A, Scheinert D (2019). [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia]. Internist (Berl), 60(2), 149-160.
     
  71. Mühlberg KS (2019). PAVK: Diagnostik und Indikation vor Intervention CARDIOVASC, 19, 42-46.
     
  72. Teichgraber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, Sixt S, Brucks S, Beschorner U, Klumb CT, Thieme M (2019). Efficacy and Safety of a Novel Paclitaxel-Nano-Coated Balloon for Femoro-Popliteal Angioplasty: 1-Year Results of EffPac Trial. EuroIntervention, 10, 42-44.
     
  73. Ouriel K, Adelman MA, Rosenfield K, Scheinert D, Brodmann M, Pena C, Geraghty P, Lee A, White R, Clair DG (2019). Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. JACC Cardiovasc Interv, 10, 10-16.
     
  74. Clauder F, Czerniak AS, Friebe S, Mayr SG, Scheinert D, Beck-Sickinger AG (2019). Endothelialization of Titanium Surfaces by Bioinspired Cell Adhesion Peptide Coatings. Bioconjug Chem, 30(10), 2664-2674.
     
  75. Haensig M, Schmidt A, Staab H, Steiner S, Scheinert D, Branzan D (2019). Endovascular Repair of the Thoracic or Thoracoabdominal Aorta Following the Frozen Elephant Trunk Procedure. Ann Thorac Surg, 19, 4975.
     
  76. Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G (2019). Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. Circ Cardiovasc Interv, 12(6), 007702-.
     
  77. Laird JR, Zeller T, Holden A, Scheinert D, Moore E, Mendes R, Schmiedel R, Settlage R, Lansky A, Jaff MR (2019). Balloon-Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: 9-Month Results from the BOLSTER Multicenter Study. J Vasc Interv Radiol, 30(6), 836-844.
     
  78. Tepe G, Micari A, Keirse K, Zeller T, Scheinert D, Li P, Schmahl R, Jaff MR (2019). Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study. JACC Cardiovasc Interv, 12(5), 484-493.
     
  79. Langhoff R, Schofer J, Scheinert D, Schmidt A, Sedgewick G, Saylors E, Sachar R, Sievert H, Zeller T (2019). Double Filtration During Carotid Artery Stenting Using a Novel Post-Dilation Balloon With Integrated Embolic Protection. JACC Cardiovasc Interv, 12(4), 395-403.
     
  80. Zeller T, Brodmann M, Micari A, Keirse K, Peeters P, Tepe G, Scheinert D, Jaff MR, Rocha-Singh KJ, Li P, Schmahl R, Ansel GM (2019). Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain. Circ Cardiovasc Interv, 12(1), 007730-.
     
  81. Paschke L, Lincke T, Mühlberg K, Lindner TH, Paschke R (2019). Myocardial Infarction after Long-Term Treatment with a Tyrosine Kinase Inhibitor (TKI) with Anti-VEGF Receptor Activity. Hindawi Case Reports in Endocrinology, 7927450, 1-3.
     


  82. 2018


  83. Scheinert D, Micari A, Brodmann M, Tepe G, Peeters P, Jaff MR, Wang H, Schmahl R, Zeller T (2018). Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease. Circ Cardiovasc Interv, 11(10), e005654-.
     
  84. Branzan D, Etz CD, Moche M, Von Aspern K, Staab H, Fuchs J, Then Bergh F, Scheinert D, Schmidt A (2018). Ischaemic preconditioning of the spinal cord to prevent spinal cord ischaemia during endovascular repair of thoracoabdominal aortic aneurysm: first clinical experience. EuroIntervention, 14(7), 828-835.
     
  85. Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Strobel A, Schult I, Scheinert D (2018). 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment. JACC Cardiovasc Interv, 11(10), 934-941.
     
  86. Dias-Neto M, Matschuck M, Bausback Y, Banning-Eichenseher U, Steiner S, Branzan D, Staab H, Varcoe RL, Scheinert D, Schmidt A (2018). Endovascular Treatment of Severely Calcified Femoropopliteal Lesions Using the "Pave-and-Crack" Technique: Technical Description and 12-Month Results. J Endovasc Ther, 25(3), 334-342.
     
  87. Freitas B, Bausback Y, Schuster J, Ulrich M, Braunlich S, Schmidt A, Scheinert D (2018). Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience. Ann Vasc Surg, 51, 124-131.
     
  88. Thieme M, Lichtenberg M, Brodmann M, Cioppa A, Scheinert D (2018). Lutonix® 014 DCB global Below the Knee Registry Study: interim 6-month outcomes. J Cardiovasc Surg (Torino), 59(2), 232-236.
     
  89. Dohi T, Schmidt A, Scheinert D, Bausback Y, Kabata D, Shintani A, Sakata Y, Steiner S (2018). Drug-Coated Balloon Angioplasty in Atherosclerosis Patients With Popliteal Artery Involvement. J Endovasc Ther, 25(5), 581-587.
     
  90. Welling RHA, Bakker OJ, Scheinert D, Moll FL, Hazenberg CE, Mustapha JA, de Borst GJ, Schmidt A (2018). Below-the-Knee Retrograde Access for Peripheral Interventions: A Systematic Review. J Endovasc Ther, 25(3), 345-352.
     
  91. Branzan D, Schmidt A (2018). Emergency Endovascular Treatment of Contained Aortic Rupture of Chronic Type B Aortic Dissection Using the Candy-Plug Technique. Eur J Vasc Endovasc Surg, 56(4), 561-.
     
  92. Shammas NW, Pucillo A, Jenkins JS, Garcia LA, Davis T, Aronow HD, Armstrong EJ, Zeller T, Scheinert D, Rosenschein U, Gray W (2018). WIRION Embolic Protection System in Lower Extremity Arterial Interventions: Results of the Pivotal WISE LE Trial. JACC Cardiovasc Interv, 11(19), 1995-2003.
     
  93. Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Muller-Hulsbeck S (2018). A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet, 0140, 6736.
     
  94. Bosiers M, Deloose K, Torsello G, Scheinert D, Maene L, Peeters P, Muller-Hulsbeck S, Sievert H, Langhoff R, Callaert J, Setacci C, Wauters J (2018). The CLEAR-ROAD study: Evaluation of a new dual layer micromesh stent system for the carotid artery: 12-month results. EuroIntervention, 18, 00230.
     
  95. Chernin G, Szwarcfiter I, Scheinert D, Blessing E, Diehm N, Dens J, Walton A, Verheye S, Shetty S, Jonas M (2018). First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant Hypertension. J Vasc Interv Radiol, 29(8), 1158-1166.
     
  96. Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, Wang H, Zeller T (2018). Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study. JACC Cardiovasc Interv, 11(10), 945-953.
     
  97. Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P (2018). Response by Schneider et al to Letter Regarding Article, "Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial". Circ Cardiovasc Interv, 11(6), 006699-.
     
  98. Jeger RV, Farah A, Ohlow MA, Mangner N, Mobius-Winkler S, Leibundgut G, Weilenmann D, Wohrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N (2018). Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet, 392(10150), 849-856.
     
  99. Branzan D, Winkler D, Schmidt A, Scheinert D, Grunert R (2018). Three-Dimensional Aortic Model to Create a Fenestrated Stent Graft for the Urgent Treatment of a Paravisceral Penetrating Aortic Ulcer. JACC Cardiovasc Interv, 18, 1-3.
     
  100. Donas KP, Taneva GT, Pitoulias GA, Torsello G, Veith FJ (2018). Coexisting hypogastric aneurysms worsen the outcomes of endovascular treatment by the iliac branch devices within the pELVIS Registry. J Vasc Surg, 18, 1-5.
     
  101. Brodmann M, Werner M, Holden A, Tepe G, Scheinert D, Schwindt A, Wolf F, Jaff M, Lansky A, Zeller T (2018). Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. Catheter Cardiovasc Interv, 25, 1-5.
     
  102. Luehr M, Etz CD, Berezowski M, Nozdrzykowski M, Jerkku T, Peterss S, Borger MA, Czerny M, Banafsche R, Pichlmaier MA, Beyersdorf F, Hagl C, Schmidt A, Rylski B (2018). Outcomes after thoracic endovascular aortic repair with overstenting of the left subclavian artery. Ann Thorac Surg, 30, 1-5.
     
  103. Schmidt A, Scheinert D (2018). Zugangswege und Punktionstechniken. In: Ulf Teichgräber, Rene Aschenbach, Dierk Scheinert, Andrej Schmidt, Periphere arterielle Interventionen. (S. 115-130), Deutschland: Springer Verlag.
     
  104. Steiner S (2018). Prä-, peri- und postinterventionelle Antikoagulation. In: Ulf Teichgräber, Rene Aschenbach, Dierk Scheinert, Andrej Schmidt, Periphere arterielle Interventionen. (S. 155-162), Deutschland: Springer Verlag.
     
  105. Schmidt A, Scheinert D (2018). Behandlungsstrategien bei kritischer Ischämie und chronischen femoropoplitealen Verschlüssen In: Ulf Teichgräber, Rene Aschenbach, Dierk Scheinert, Andrej Schmidt, Periphere arterielle Interventionen (S. 301-314), Deutschland: Springer Verlag.
     


  106. 2017


  107. Freitas B, Steiner S, Bausback Y, Staab H, Branzan D, Banning-Eichenseer U, Schmidt A, Scheinert D (2017). Single center experience with vascular closure devices in real-world endovascular peripheral interventions. J Cardiovasc Surg (Torino), 0, 0.
     
  108. Storck M, Nolte T, Tenholt M, Maene L, Maleux G, Scheinert D (2017). Women and men derive comparable benefits with an ultra low-profile endograft: 1-year results of the European OVATION registry. J Cardiovasc Surg (Torino), 58(5), 658-664.
     
  109. Freitas B, Steiner S, Bausback Y, Branzan D, Ulrich M, Braunlich S, Schmidt A, Scheinert D (2017). Rotarex Mechanical Debulking in Acute and Subacute Arterial Lesions: Single-Center Experience With 525 Patients. Angiology, 68(3), 233-241.
     
  110. Harzendorf C, Schmidt A, Hirsch T (2017). [Prostate carcinoma + swelling of the leg = lymphedema : Is the equation correct?] Internist (Berl), 58(4), 402-408.
     
  111. Schmidt A, Bakker OJ, Bausback Y, Scheinert D (2017). The tibiopedal retrograde vascular access for challenging popliteal and below-the-knee chronic total occlusions: literature review and description of the technique. J Cardiovasc Surg (Torino), 58(3), 371-382.
     
  112. Scheinert D, Reimers B, Cremonesi A, Schmidt A, Sievert H, Rohde S, Schofer J, Mudra HG, Bosiers M, Zeller T, Pacchioni A, Rosenschein U (2017). Independent Modular Filter for Embolic Protection in Carotid Stenting. Circ Cardiovasc Interv, 10(3), e004244.
     
  113. Bausback Y, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Strobel A, Schult I, Scheinert D (2017). Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment. J Endovasc Ther, 24(4), 459-467.
     
  114. Deloose K, Bosiers M, Callaert J, Verbist J, Vermassen F, Scheinert D, Torsello G, Peeters P (2017). Primary stenting is nowadays the golden standard treatment for TASC II A & B iliac lesions: The definitive MISAGO 1-year results. J Cardiovasc Surg (Torino), 58(3), 416-421.
     
  115. Pratesi G, Pratesi C, Chiesa R, Coppi G, Scheinert D, Brunkwall JS, Van der Meulen S, Torsello G (2017). The INNOVATION Trial: four-year safety and effectiveness of the INCRAFT® AAA Stent-Graft System for endovascular repair. J Cardiovasc Surg (Torino), 58(5), 650-657.
     
  116. Bosiers MJ, Deloose K, Peeters P, Torsello G, Zeller T, Scheinert D, Schmidt A, Maene L, Keirse K, Varcoe R, Bosiers M (2017). Outcome of a drug-eluting stent in longer below-the-knee lesions in patients with critical limb ischemia. J Cardiovasc Surg (Torino), 58(1), 49-54.
     
  117. Kum S, Tan YK, Schreve MA, Ferraresi R, Varcoe RL, Schmidt A, Scheinert D, Mustapha JA, Lim DM, Ho D, Tang TY, Alexandrescu VA, Mutirangura P (2017). Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia. J Endovasc Ther, 24(5), 619-626.
     
  118. Brodmann M, Keirse K, Scheinert D, Spak L, Jaff MR, Schmahl R, Li P, Zeller T (2017). Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort. JACC Cardiovasc Interv, 10(20), 2113-2123.
     
  119. Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, Krzanowski M, Peeters P, Scheinert D, Torsello G, Sixt S, Tepe G (2017). Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study. Circ Cardiovasc Interv, 10(9), e004848.
     
  120. Hammad TA, Zeller T, Baumgartner I, Scheinert D, Rocha-Singh KJ, Shishehbor MH (2017). Analysis of IN.PACT DEEP trial on the association between changes in perfusion from pre- to postrevascularization and clinical outcomes in critical limb ischemia. Catheter Cardiovasc Interv, 90(6), 986-993.
     
  121. Zeller T, Krankenberg H, Erglis A, Blessing E, Fuss T, Scheinert D, Weser R, Doerr BB, Yollo WD, Radermacher J (2017). A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study. Trials, 18(1), 380.
     
  122. Nozdrzykowski M, Garbade J, Leinung S, Schmidt A, Mohr FW, Borger MA (2017). Thoracic Endovascular Aortic Repair for Aortoesophageal Fistula after Covered Rupture of Aortic Homograft. Aorta (Stamford), 5(3), 96-100.
     


  123. 2016


  124. Katsanos K, Spiliopoulos S, Diamantopoulos A, Siablis D, Karnabatidis D, Scheinert D (2016). Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease. JACC Cardiovasc Interv, 9(3), 259-267.
     
  125. Werner M, Schmidt A, Scheinert S, Banning-Eichenseer U, Ulrich M, Bausback Y, Steiner S, Scheinert D (2016). Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study. J Endovasc Ther, 23(1), 92-97.
     
  126. Steiner S, Schmidt A, Bausback Y, Piorkowski M, Werner M, Yahiaoui-Doktor M, Banning-Eichenseer U, Scheinert D (2016). Midterm Patency After Femoropopliteal Interventions: A Comparison of Standard and Interwoven Nitinol Stents and Drug-Coated Balloons in a Single-Center, Propensity Score-Matched Analysis. J Endovasc Ther, 23(2), 347-355.
     
  127. Scheinert D, Schmidt A, Zeller T, Muller-Hulsbeck S, Sixt S, Schroder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K (2016). German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. J Endovasc Ther, 23(3), 409-416.
     
  128. Steiner S, Schmidt A, Bausback Y, Braunlich S, Ulrich M, Banning-Eichenseer U, Scheinert D (2016). Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries. J Endovasc Ther, 23(3), 417-423.
     
  129. Schmidt A, Piorkowski M, Gorner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D (2016). Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry. JACC Cardiovasc Interv, 9(7), 715-724.
     
  130. Scheinert D, Schmidt A (2016). CardioPulse: Elevating endovascular aneurysm repair to new heights. Eur Heart J, 37(4), 332-333.
     
  131. Cortese B, Granada JF, Scheller B, Schneider PA, Tepe G, Scheinert D, Garcia L, Stabile E, Alfonso F, Ansel G, Zeller T (2016). Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document. Eur Heart J, 37(14), 1096-1103.
     
  132. Shishehbor MH, Hammad TA, Zeller T, Baumgartner I, Scheinert D, Rocha-Singh KJ (2016). An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb ischemia. J Vasc Surg, 63(5), 1311-1317.
     
  133. Lammer J, Bosiers M, Deloose K, Schmidt A, Zeller T, Wolf F, Lansink W, Sauguet A, Vermassen F, Lauwers G, Scheinert D, Popma JJ, McGreevy R, Rapoza R, Schwartz LB, Jaff MR (2016). Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results. JACC Cardiovasc Interv, 9(11), 1178-1187.
     
  134. Bosiers M, Deloose K, Torsello G, Scheinert D, Maene L, Peeters P, Muller-Hulsbeck S, Sievert H, Langhoff R, Bosiers M, Setacci C (2016). The CLEAR-ROAD study: evaluation of a new dual layer micromesh stent system for the carotid artery. EuroIntervention, 12(5), e671-676.
     
  135. Bosiers M, Scheinert D, Hendriks JM, Wissgott C, Peeters P, Zeller T, Brodmann M, Staffa R (2016). Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg, 64(1), 109-116.
     
  136. Teichgraber U, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Thieme M, Blessing E, Treitl M, Lichtenberg M, von Flowtow P, Vogel B, Werk M, Riambau V, Wienke A, Lehmann T, Sixt S (2016). The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial. Trials, 17(1), 528-538.
     
  137. Nozdrzykowski M, Luehr M, Garbade J, Schmidt A, Leontyev S, Misfeld M, Mohr FW, Etz CD (2016). Outcomes of secondary procedures after primary thoracic endovascular aortic repair. Eur J Cardiothorac Surg, 49(3), 770-777.
     
  138. Brinton T, Brodmann M, Werner M, Tepe G, Holden A, Scheinert D, Wolf F, Torsello G, Lansky A, Jaff M, Zeller T (2016). TCT-777 Safety and Performance of the Shockwave Medical Lithoplasty® System in treating calcified peripheral vascular lesions: 6-Month Results from the two-phase DISRUPT PAD Study. Abstract. J Am Coll Cardiol, 68(18S), 314.
     
  139. Walker CM, Mustapha J, Zeller T, Schmidt A, Montero-Baker M, Nanjundappa A, Manzi M, Palena LM, Bernardo N, Khatib Y, Beasley R, Leon L, Saab FA, Shields AR, Adams GL (2016). Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions: A Prospective Multicenter Observational Study. J Endovasc Ther, 23(6), 839-846.
     


  140. 2015


  141. Piorkowski M, Klaffling C, Botsios S, Zerweck C, Scheinert S, Banning-Eichenseher U, Bausback Y, Scheinert D, Schmidt A (2015). Postinterventional microembolism signals detected by transcranial Doppler ultrasound after carotid artery stenting. Vasa, 44(1), 49-57.
     
  142. Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Muller-Hulsbeck S, Nehler MR, Benenati JF, Scheinert D (2015). Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med, 373(2), 145-153.
     
  143. Rosenfield K, Metzger DC, Scheinert D (2015). A Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med, 373(18), 1785-1786.
     
  144. Scheinert D, Schulte KL, Zeller T, Lammer J, Tepe G (2015). Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther, 22(1), 14-21.
     
  145. Schmidt A, Scheinert D (2015). Zugangswege zur endovaskulären Therapie der peripheren arteriellen Verschlusskrankheit. Interventionelle Radiologie Scan, 3(4), 315-331.
     
  146. Piorkowski M, Freitas B, Steiner S, Botsios S, Bausback Y, Scheinert D, Schmidt A (2015). Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries. J Cardiovasc Surg (Torino), 56(1), 89-95.
     
  147. Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ (2015). Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Am Heart J, 169(4), 479-485.
     
  148. Rastan A, Krankenberg H, Baumgartner I, Blessing E, Muller-Hulsbeck S, Pilger E, Scheinert D, Lammer J, Beschorner U, Noory E, Neumann FJ, Zeller T (2015). Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial. J Endovasc Ther, 22(1), 22-27.
     
  149. Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, Schroe H, Lansink W, Scheinert D, Schmidt A, Zeller T, Beschorner U, Noory E, Torsello G, Austermann M, Peeters P (2015). Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial. J Endovasc Ther, 22(1), 1-10.
     
  150. Jordan WD Jr, Ouriel K, Mehta M, Varnagy D, Moore WM Jr, Arko FR, Joye J, de Vries JP (2015). Outcome-based anatomic criteria for defining the hostile aortic neck. J Vasc Surg, 61(6), 1383-1390.
     
  151. Bohm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G (2015). First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension, 65(4), 766-774.
     
  152. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR (2015). Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation, 131(5), 495-502.
     
  153. Zeller T, Beschorner U, Pilger E, Bosiers M, Deloose K, Peeters P, Scheinert D, Schulte KL, Rastan A, Brodmann M (2015). Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIKS-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC Cardiovasc Interv, 8(12), 1614-1622.
     
  154. Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR (2015). Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. J Am Coll Cardiol, 66(21), 2329-2338.
     
  155. Krankenberg H, Tubler T, Ingwersen M, Schluter M, Scheinert D, Blessing E, Sixt S, Kieback A, Beschorner U, Zeller T (2015). Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial. Circulation, 132(23), 2230-2236.
     
  156. Torres-Blanco A, Schmidt A, Gomez-Palones F, Ortiz-Monzon E (2015). The Roadside Technique for Type II Endoleak Embolization 4 Years after Endovascular Aortic Aneurysm Repair. Ann Vasc Surg, 29(4), 837.
     
  157. Bosiers M, Scheinert D, Mathias K, Langhoff R, Mudra H, Diaz-Cartelle J (2015). Carotid stenting with distal protection in high-surgical-risk patients: one-year results of the ASTI trial. Cardiovasc Intervent Radiol, 38(2), 295-303.
     


  158. 2014


  159. Schmidt A, Scheinert D (2014). [Interventional treatment of peripheral artery occlusive disease]. Dtsch Med Wochenschr, 139(40), 1979-1981.
     
  160. Werner M, Scheinert D (2014). Drug eluting devices for critically ill patients: can we apply lessons learned from the treatment of peripheral artery disease? Adv Drug Deliv Rev, 77, 32-39.
     
  161. Bausback Y, Friedenberger J, Hertting K, Werner M, Branzan D, Freitas B, Piorkowski M, Schmidt A, Scheinert D (2014). Renal denervation for hypertension refractory to renal artery stenting. J Endovasc Ther, 21(2), 181-190.
     
  162. Werner M, Paetzold A, Banning-Eichenseer U, Scheinert S, Piorkowski M, Ulrich M, Bausback Y, Braunlich S, Schmidt A, Scheinert D (2014). Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention, 10(7), 861-868.
     
  163. Schmidt A, Zeller T, Sievert H, Krankenberg H, Torsello G, Stark MA, Scheinert D (2014). Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. J Endovasc Ther, 21(1), 52-60.
     
  164. Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K (2014). The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv, 7(1), 10-19.
     
  165. Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U (2014). Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial. J Endovasc Ther, 21(6), 765-774.
     
  166. Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M, Snead DB, Kent KC, Rocha-Singh KJ (2014). Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol, 64(15), 1568-1576.
     
  167. de Vries JP, Ouriel K, Mehta M, Varnagy D, Moore WM Jr, Arko FR, Joye J, Jordan WD Jr (2014). Analysis of EndoAnchors for endovascular aneurysm repair by indications for use. J Vasc Surg, 60(6), 1460-1467.
     
  168. Jordan WD Jr, Mehta M, Varnagy D, Moore WM Jr, Arko FR, Joye J, Ouriel K, de Vries JP (2014). Results of the ANCHOR prospective, multicenter registry of EndoAnchors for type Ia endoleaks and endograft migration in patients with challenging anatomy. J Vasc Surg, 60(4), 885-892.
     
  169. Botsios S, Bausback Y, Piorkowski M, Werner M, Branzan D, Scheinert D, Schmidt A (2014). Late open conversion after endovascular aneurysm repair. Interact Cardiovasc Thorac Surg, 19(4), 622-626.
     
  170. Stabile E, Biamino G, Cremonesi A, Dudek D, Rubino P, Scheinert D, Reimers B, Sievert H, Schroth G, Balzer JO (2014). The DESERVE study: diffusion weighted-MRI based evaluation of the effectiveness of endovascular clamping during carotid artery stenting with the Mo.Ma device. Int J Cardiol, 174(2), 382-383.
     
  171. Laird JR, Jain A, Zeller T, Feldman R, Scheinert D, Popma JJ, Armstrong EJ, Jaff MR (2014). Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial. J Endovasc Ther, 21(2), 202-212.
     
  172. Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M (2014). IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials, 15, 63.
     
  173. Werner M, Micari A, Cioppa A, Vadala G, Schmidt A, Sievert H, Rubino P, Angelini A, Scheinert D, Biamino G (2014). Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study. JACC Cardiovasc Interv, 7(3), 305-312.
     
  174. Bosiers M, Diaz-Cartelle J, Scheinert D, Peeters P, Dawkins KD (2014). Revascularization of lower extremity chronic total occlusions with a novel intraluminal recanalization device: results of the ReOpen study. J Endovasc Ther, 21(1), 61-70.
     
  175. Coppi G, Njila M, Coppi G, Saitta G, Silingardi R, Pratesi C, Chiesa R, Scheinert D, Brunkwall JS, Torsello G (2014). INCRAFT® Stent-Graft System: one-year outcome of the INNOVATION Trial. J Cardiovasc Surg (Torino), 55(1), 51-59.
     
  176. Mehta M, Valdes FE, Nolte T, Mishkel GJ, Jordan WD, Gray B, Eskandari MK, Botti C (2014). One-year outcomes from an international study of the Ovation Abdominal Stent Graft System for endovascular aneurysm repair. J Vasc Surg, 59(1), 65-73.